Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > What's with Morgan Stanley Canada hitting the bid with 100
View:
Post by Noteable on Nov 29, 2024 4:09pm

What's with Morgan Stanley Canada hitting the bid with 100

Looks like Morgan Stanley Canada is trying to manipulate ONC.TO share price by continuously hitting the bid with the sale of 100 shares over the course of each day, and as the last trade of each day, which the provincial regulators should be made aware of.
Comment by Noteable on Nov 29, 2024 4:52pm
This likely has to do with Morgan Stanley, Goldman Sachs & Co. LLC and Cantor previusly acting as joint book-running managers for the CG Oncology's IPO in January 2024 https://cgoncology.com/cg-oncology-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares/.
Comment by Noteable on Nov 29, 2024 4:56pm
Intravessical dekuivered OV company CG Oncology was IPO'ed at US$19.00 and today closed up 1.91% at US$34.75
Comment by Noteable on Nov 29, 2024 4:58pm
Should read: Intravesical delivered OV company CG Oncology
Comment by Noteable on Nov 29, 2024 5:52pm
The OV company CG Oncology with a single target of Non-muscle invasic bladder cancer (NMIBC) has a market ap of US$2.35 Billion at today's close. https://cgoncology.com/pipeline/
Comment by Noteable on Nov 29, 2024 5:54pm
"  single target of Non-muscle invasive bladder cancer (NMIBC) "
Comment by Noteable on Nov 29, 2024 5:59pm
Recent Trades - Last 10 of 356   Time ET Ex Price Change Volume Buyer Seller Markers 16:00:00 T 1.32 -0.06 6 7 TD Sec 7 TD Sec Q 16:00:00 T 1.32 -0.06 100 79 CIBC 53 Morgan ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities